Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction, and Fatty Liver Disease
TLDR
In this paper, the authors describe the mechanisms of gut dysbiosis, leaky gut, endotoxemia, and fatty liver disease with a specific focus on the alcohol-associated pathways.Abstract:
Emerging data demonstrate the important roles of altered gut microbiomes (dysbiosis) in many disease states in the peripheral tissues and the central nervous system. Gut dysbiosis with decreased ratios of Bacteroidetes/Firmicutes and other changes are reported to be caused by many disease states and various environmental factors, such as ethanol (e.g., alcohol drinking), Western-style high-fat diets, high fructose, etc. It is also caused by genetic factors, including genetic polymorphisms and epigenetic changes in different individuals. Gut dysbiosis, impaired intestinal barrier function, and elevated serum endotoxin levels can be observed in human patients and/or experimental rodent models exposed to these factors or with certain disease states. However, gut dysbiosis and leaky gut can be normalized through lifestyle alterations such as increased consumption of healthy diets with various fruits and vegetables containing many different kinds of antioxidant phytochemicals. In this review, we describe the mechanisms of gut dysbiosis, leaky gut, endotoxemia, and fatty liver disease with a specific focus on the alcohol-associated pathways. We also mention translational approaches by discussing the benefits of many antioxidant phytochemicals and/or their metabolites against alcohol-mediated oxidative stress, gut dysbiosis, intestinal barrier dysfunction, and fatty liver disease.read more
Citations
More filters
Journal ArticleDOI
CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload
TL;DR: CYP2E1 is one of the fifty-seven cytochrome P450 genes in the human genome and is highly conserved as discussed by the authors, which has been the focus of scientific interest due to its important endogenous function in liver homeostasis.
Journal ArticleDOI
The Influence of Gut Dysbiosis in the Pathogenesis and Management of Ischemic Stroke
Saravana Babu Chidambaram,A.G. Rathipriya,Arehally M. Mahalakshmi,Sonali Sharma,Tousif Ahmed Hediyal,Bipul Chandra Ray,Tuladhar Sunanda,Wiramon Rungratanawanich,Rajpal S. Kashyap,M. Walid Qoronfleh,Musthafa Mohamed Essa,Byoung Joon Song,Tanya Monaghan +12 more
TL;DR: It is demonstrated that the restoration of the gut microbiome usually improves stroke treatment outcomes by regulating metabolic, immune, and inflammatory responses via the gut–brain axis (GBA).
Journal ArticleDOI
Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Saravana Babu Chidambaram,Saravana Babu Chidambaram,Musthafa Mohamed Essa,John R. Campbell,Musthafa Mohamed Essa,A.G. Rathipriya,Muhammed Bishir,Bipul Ray,Arehally M. Mahalakshmi,A. H. Tousif,Meena Kishore Sakharkar,Rajpal S. Kashyap,Robert P. Friedland,Tanya Monaghan +13 more
TL;DR: In this paper, a review summarizes the current understanding of the role of the gut microbiota in NDDs, and highlights a vicious cycle of gut dysbiosis, immune-mediated chronic neuroinflammation, impaired autophagy and proteinopathies, which contributes to the development of neurodegeneration in Alzheimer's disease, Parkinson disease, Huntington disease, multiple sclerosis, amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Journal ArticleDOI
Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review
S Sonali,Bipul Chandra Ray,Hediyal Ahmed Tousif,A.G. Rathipriya,Tuladhar Sunanda,Arehally M. Mahalakshmi,Wiramon Rungratanawanich,Musthafa Mohamed Essa,M. Walid Qoronfleh,Saravana Babu Chidambaram,Byoung Joon Song +10 more
TL;DR: The etiopathogenic link between gut dysbiosis and depression with preclinical and clinical evidence is summarized and information on the recent therapies and supplements, such as probiotics, prebiotics, short-chain fatty acids, and vitamin B12, omega-3 fatty acid, etc., which target the gut–brain axis (GBA) for the effective management of depressive behavior and anxiety are collated.
Journal ArticleDOI
The Gut-Liver Axis in Chronic Liver Disease: A Macrophage Perspective.
TL;DR: In this article, the role of intestinal and hepatic macrophages in homeostasis and gut-liver axis disruption in progressive stages of chronic liver disease (CLD) is discussed.
References
More filters
Journal ArticleDOI
Enterotypes of the human gut microbiome
Manimozhiyan Arumugam,Jeroen Raes,Eric Pelletier,Denis Le Paslier,Takuji Yamada,Daniel R. Mende,Gabriel Fernandes,Julien Tap,Thomas Brüls,Jean-Michel Batto,Marcelo Bertalan,Natalia Borruel,Francesc Casellas,Leyden Fernández,Laurent Gautier,Torben Hansen,Masahira Hattori,Tetsuya Hayashi,Michiel Kleerebezem,Ken Kurokawa,Marion Leclerc,Florence Levenez,Chaysavanh Manichanh,H. Bjørn Nielsen,Trine Nielsen,Nicolas Pons,Julie Poulain,Junjie Qin,Thomas Sicheritz-Pontén,Sebastian Tims,David Torrents,Edgardo Ugarte,Erwin G. Zoetendal,Jun Wang,Francisco Guarner,Oluf Pedersen,Willem M. de Vos,Søren Brunak,Joël Doré,Jean Weissenbach,S. Dusko Ehrlich,Peer Bork +41 more
TL;DR: Three robust clusters (referred to as enterotypes hereafter) are identified that are not nation or continent specific and confirmed in two published, larger cohorts, indicating that intestinal microbiota variation is generally stratified, not continuous.
Journal ArticleDOI
Steatohepatitis: a tale of two "hits"?
Journal ArticleDOI
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
TL;DR: Gallic acid and isoflavones are the most well-absorbed polyphenols, followed by catechins, flavanones, and quercetin glucosides, but with different kinetics, and the least well- absorption polyphenol are the proanthocyanidins, the galloylated tea catech ins, andThe anthocyanins.
Journal ArticleDOI
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
Gijs den Besten,Karen van Eunen,Albert K. Groen,Koen Venema,Dirk-Jan Reijngoud,Barbara M. Bakker +5 more
TL;DR: This review summarizes the role of SCFAs in host energy metabolism, starting from the production by the gut microbiota to the uptake by the host and ending with the effects on host metabolism.
Journal ArticleDOI
Intestinal mucosal barrier function in health and disease.
TL;DR: Recent advances have uncovered mechanisms by which the intestinal mucosal barrier is regulated in response to physiological and immunological stimuli, along with evidence that this regulation shapes mucosal immune responses in the gut and, when dysfunctional, may contribute to disease.
Related Papers (5)
The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)
Zahra Safari,Philippe Gérard +1 more